# The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

> **NCT00838968** · NA · WITHDRAWN · sponsor: **Fudan University**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** interferon-alpha

## Key facts

- **NCT ID:** NCT00838968
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2012-10
- **Final completion:** 2013-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** we have found another marker (microRNA26) which is more sensitive to evaluate the effect of postoperative IFNa treatment in patients with HCC
- **Last updated:** 2012-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838968, "The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00838968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*